Clinical Trial Update: Randomized Trial Comparing Sirolimus and Tacrolimus Versus Cyclosporine and Methotrexate as Graft-versus-host Disease (GVHD) Prophylaxis After Allogeneic Stem Cell Transplantation [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing sirolimus plus tacrolimus versus cyclosporine plus methotrexate for graft-versus-host disease prophylaxis after allogeneic st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Neoral (cyclosporine) (cyclosporine)
• Prograf (Tacrolimus) (Tacrolimus)
• Rapamune (sirolimus) (sirolimus)
• Trexall (methotrexate) (methotrexate)

Snippet

Sponsor: Karolinska Institutet | Conditions: Graft-versus-host Disease, Survival | Phase 3 | Status: COMPLETED